Press Release

 View printer-friendly version
<< Back
Novavax to Host Conference Call to Discuss First Quarter 2017 Financial Results on May 8, 2017

GAITHERSBURG, Md., May 01, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its first quarter 2017 financial and operating results following the close of U.S. financial markets on Monday, May 8, 2017.

Conference call details are as follows:

Date:      Monday, May 8, 2017
Time:    4:30 p.m. U.S. Eastern Time (ET)
Dial-in number:   (877) 212-6076 (Domestic) or (707) 287-9331 (International)
Passcode:   15607801
Webcast:    www.novavax.com, “Investors”/ “Events” 

Conference call and webcast replay:

Dates:      Starting at 7:30 p.m. ET, May 8, 2017, until 7:30 p.m. ET, May 15, 2017 
Dial-in number:    (855) 859-2056 (Domestic) or (404) 537-3406 (International)
Passcode:    15607801
Webcast:    www.novavax.com, “Investors”/ “Events”

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Its recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines.

Contact:

Investor Relations
Novavax, Inc.
Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations
ir@novavax.com
240-268-2000

Westwicke Partners
John Woolford
john.woolford@westwicke.com
443-213-0506

Media
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull@russopartnersllc.com
212-845-4271

Primary Logo

Novavax, Inc.